The Valvular Interventions Center

Filter Your Results




Five-Year Data From NOTION and Extreme-Risk Trials Presented for Medtronic's CoreValve TAVR Systems

March 10, 2018 -- Medtronic announced that outcomes from the real-world Nordic Aortic Valve Intervention Trial (NOTION) and the CoreValve United States Pivotal Extreme Risk St…

Abbott's Masters HP 15-mm Pediatric Heart Valve Approved by FDA

March 8, 2018 -- Abbott announced that the US Food and Drug Administration (FDA) approved its Masters HP 15-mm rotatable mechanical heart valve, which will allow doctors to tr…

Early and Newer-Generation TAVR Devices Compared in Patients With Native Aortic Valve Regurgitation

March 5, 2018 -- Danny Dvir, MD, presented the results of a trial investigating transcatheter aortic valve replacement (TAVR) for the treatment of pure native aortic valve reg…

Early Results Presented for Edwards' Sapien M3 System to Treat Mitral Regurgitation

March 5, 2018 -- John Webb, MD, presented "encouraging" findings from the early experience with the Sapien M3 system (Edwards Lifesciences) for the treatment of mitr…

REAC-TAVI Evaluates Ticagrelor to Suppress Platelet Reactivity After TAVR

March 5, 2018 -- Ticagrelor is more effective than clopidogrel at suppressing high platelet reactivity after transcatheter aortic valve replacement (TAVR) in patients with sev…

Early Results Presented From Low-Risk TAVR Study

March 5, 2018 -- Ron Waksman, MD, presented an interim analysis of a study assessing the safety and feasibility of transcatheter aortic valve replacement (TAVR) with commercia…

Combining Frailty With Conventional Risk Scores Shown to Improve Mortality Prediction After TAVR

February 26, 2018 -- In Journal of the American College of Cardiology: Cardiovascular Interventions, Andreas W. Schoenenberger, MD, et al published findings from a study showi…

Ask the Experts: What Is the Role of Mitral Repair in Heart Failure?

With William Weir, MD; Steven F. Bolling, MD; Brian Whisenant, MD; Nyal Borges, MD; Samir Kapadia, MD, FACC, FSCAI; Muath Bishawi, MD; and Donald D. Glower Jr, MD

January/February 2018—Experts discuss treatment strategies for patients with mitral regurgitation progressing to heart failure.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.